This inventor holds 2 USPTO granted patents and 4 published patent applications. Top assignee: Tapi Czech Industries S.r.o.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Adéla Bártová: Innovator in Pharmaceutical Solid State Forms
Introduction
Adéla Bártová is a prominent inventor based in Ostrava, Czech Republic. He has made significant contributions to the field of pharmaceuticals, particularly in the development of solid state forms of various compounds. With a total of 2 patents to his name, Bártová's work is paving the way for advancements in drug formulation and delivery.
Latest Patents
Bártová's latest patents include innovative formulations that enhance the efficacy of pharmaceutical compounds. One of his notable patents is focused on solid state forms of Lorecivivint. This patent encompasses crystalline polymorphs of Lorecivivint, detailing processes for their preparation and pharmaceutical compositions. Another significant patent involves the solid state form of lemborexant, which includes Lemborexant:succinic acid, along with processes for its preparation and related pharmaceutical compositions. These inventions are crucial for improving the stability and bioavailability of these compounds.
Career Highlights
Throughout his career, Adéla Bártová has demonstrated a strong commitment to research and innovation in the pharmaceutical industry. His work at Tapi Czech Industries S.r.o. has allowed him to collaborate with other experts in the field, further enhancing the impact of his inventions. Bártová's dedication to advancing pharmaceutical science is evident in his successful patent applications and ongoing research efforts.
Collaborations
Bártová has worked alongside talented colleagues such as Pavel Kolesa and Alexandr Jegorov. Their collaborative efforts have contributed to the development of groundbreaking pharmaceutical solutions, showcasing the importance of teamwork in the innovation process.
Conclusion
Adéla Bártová is a key figure in the realm of pharmaceutical innovations, particularly in the area of solid state forms. His patents reflect a deep understanding of drug formulation, and his work continues to influence the industry positively. The advancements he has made are essential for the future of pharmaceutical development.